Déjà Vu: Revived Mifepristone Case Puts FDA And Pharma At Risk Again

 
• By Sarah Karlin-Smith
  
Three pill bottles of mifepristone.
Litigation over abortion pill mifepristone once again puts the entire FDA approval process at risk. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Litigation

More from Legislation